Fundo

A pandemia da doença 2019 do coronavirus (COVID-19) afetou pessoas que sofrem de transtornos do uso de substâncias (SUDs) em todo o mundo. O objetivo deste estudo foi investigar as mudanças no número de episódios de tratamento de SUD fornecidos durante o pico da pandemia, bem como as percepções dos provedores de tratamento de SUD do impacto das restrições COVID-19-related em pessoas com SUDs e a entrega de serviços de tratamento de SUD na África do Sul.

Métodos

Usamos dados administrativos coletados como parte do projeto South African Community Epidemiology Network on Drug Use...

Summary

Substance use risks are significantly higher for people who obtain drugs on the unregulated market as there is no quality control and drug contents are unpredictable. This lack of predictability has increased during the COVID-19 pandemic as supply chains have been disrupted by border closures and safety measures. This leaves people who use drugs (PWUD) increasingly susceptible to consuming adulterated or unfamiliar substances. In some regions, COVID safety measures have also reduced capacity and access to services for PWUD, making it more difficult to prevent and address the health...

The Canadian Centre for Substance Use and Addiction (CCSA) in partnership with the Royal Ottawa Mental Health Centre, the Canadian Psychological Association and Canada Health Infoway, collected national data on the experience and perceptions of virtual services and supports, including education and access to health care or treatment.

COVID-19 safety restrictions drove the need for online and phone services to replace face-to-face counselling and supports. People using substances are experiencing virtual services differently depending on their age, gender and where they are in Canada. It was...

The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies. This study compares gender inequalities in methadone-based treatment plan progress to counseling-based programs in one of the biggest SUD treatment systems in the United States.

The...

In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of opioid use disorder (OUD). The objective of this study is to investigate the safety and tolerability of high-dose (>12 mg) buprenorphine induction for patients with OUD presenting to an ED.

Data were manually extracted from electronic health records for all ED patients with OUD treated with buprenorphine at a single, urban, safety-net hospital in Oakland...